276 related articles for article (PubMed ID: 23593253)
1. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.
Kantele A; Pakkanen SH; Karttunen R; Kantele JM
PLoS One; 2013; 8(4):e60583. PubMed ID: 23593253
[TBL] [Abstract][Full Text] [Related]
2. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
Pakkanen SH; Kantele JM; Herzog C; Kantele A
Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
5. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
Pakkanen SH; Kantele JM; Kantele A
Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
Wang JY; Noriega FR; Galen JE; Barry E; Levine MM
Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868
[TBL] [Abstract][Full Text] [Related]
8. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
9. Specific and Cross-reactive Plasmablast Response in Humans after Primary and Secondary Immunization with Vi Capsular Polysaccharide Typhoid Vaccine.
Pakkanen SH; Kantele JM; Rombo L; Kantele A
Scand J Immunol; 2017 Oct; 86(4):207-215. PubMed ID: 28675263
[TBL] [Abstract][Full Text] [Related]
10. Oral priming with Salmonella Typhi vaccine strain CVD 909 followed by parenteral boost with the S. Typhi Vi capsular polysaccharide vaccine induces CD27+IgD-S. Typhi-specific IgA and IgG B memory cells in humans.
Wahid R; Pasetti MF; Maciel M; Simon JK; Tacket CO; Levine MM; Sztein MB
Clin Immunol; 2011 Feb; 138(2):187-200. PubMed ID: 21146460
[TBL] [Abstract][Full Text] [Related]
11. Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
Tacket CO; Losonsky G; Taylor DN; Baron LS; Kopecko D; Cryz S; Levine MM
J Infect Dis; 1991 Apr; 163(4):901-4. PubMed ID: 2010645
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
[TBL] [Abstract][Full Text] [Related]
13. Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus-Responsive CD4+ and CD8+ T Cells at the Human Intestinal Mucosa.
Pennington SH; Thompson AL; Wright AK; Ferreira DM; Jambo KC; Wright AD; Faragher B; Gilmour JW; Gordon SB; Gordon MA
J Infect Dis; 2016 Jun; 213(11):1809-19. PubMed ID: 26810369
[TBL] [Abstract][Full Text] [Related]
14. IgA and IgG1 Specific to Vi Polysaccharide of
Dahora LC; Jin C; Spreng RL; Feely F; Mathura R; Seaton KE; Zhang L; Hill J; Jones E; Alam SM; Dennison SM; Pollard AJ; Tomaras GD
Front Immunol; 2019; 10():2582. PubMed ID: 31781100
[TBL] [Abstract][Full Text] [Related]
15. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
[TBL] [Abstract][Full Text] [Related]
16. Using a Human Challenge Model of Infection to Measure Vaccine Efficacy: A Randomised, Controlled Trial Comparing the Typhoid Vaccines M01ZH09 with Placebo and Ty21a.
Darton TC; Jones C; Blohmke CJ; Waddington CS; Zhou L; Peters A; Haworth K; Sie R; Green CA; Jeppesen CA; Moore M; Thompson BA; John T; Kingsley RA; Yu LM; Voysey M; Hindle Z; Lockhart S; Sztein MB; Dougan G; Angus B; Levine MM; Pollard AJ
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004926. PubMed ID: 27533046
[TBL] [Abstract][Full Text] [Related]
17. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines.
Kantele A; Arvilommi H; Kantele JM; Rintala L; Mäkelä PH
Microb Pathog; 1991 Feb; 10(2):117-26. PubMed ID: 1890950
[TBL] [Abstract][Full Text] [Related]
19. Age-Associated Heterogeneity of Ty21a-Induced T Cell Responses to HLA-E Restricted
Rudolph ME; McArthur MA; Magder LS; Barnes RS; Chen WH; Sztein MB
Front Immunol; 2019; 10():257. PubMed ID: 30886613
[TBL] [Abstract][Full Text] [Related]
20. Vaccines for preventing typhoid fever.
Milligan R; Paul M; Richardson M; Neuberger A
Cochrane Database Syst Rev; 2018 May; 5(5):CD001261. PubMed ID: 29851031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]